Therapeutic education session to promote adapted physical activity for people with inflammatory bowel disease
Official title: Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
Run by University Hospital, Toulouse · NCT07305454 · Data updated 2026-11-12
This project will try a single therapeutic education session to see if it helps adults with Crohn’s disease or ulcerative colitis in remission stick with adapted physical activity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 71 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | August 10, 2027 |
| Study ends | February 10, 2029 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07305454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a confirmed diagnosis of Crohn's disease or ulcerative colitis who have been in clinical remission for at least three months, have social security coverage, can consent, and have no medical contraindications to exercise are ideal candidates.
✕Probably not a fit
Patients with active IBD, pregnant or breastfeeding women, those under legal guardianship, or people with cardiovascular, rheumatic, or neurological contraindications to exercise are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a feasibility observational study testing whether one targeted patient therapeutic education (PTE) session about the digestive and systemic benefits of adapted physical activity (APA) increases patient adherence to APA. Adults with confirmed Crohn's disease or ulcerative colitis in clinical remission will be invited to a single in-person education session at CHU Toulouse and will complete IBD-specific questionnaires and the Short International Physical Activity Questionnaire (IPAQ) before and after the intervention. The study will compare reported physical activity levels and related symptom scores to gauge short-term change in engagement and barriers to exercise. The primary focus is real-world acceptability and preliminary signal of improved adherence rather than proving long-term clinical outcomes.
Why it matters
Potential benefit: If successful, this approach could increase patient engagement with adapted physical activity and thereby reduce fatigue, anxiety, digestive symptoms, and improve quality of life.
How similar studies have gone: Adapted physical activity has shown benefits for fatigue and quality of life in IBD, but a single-session targeted therapeutic education intervention to improve APA adherence has not been specifically tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of Inflammatory Bowel Disease * Crohn's disease in clinical remission (defined by a Harvey Bradshaw Index ≤ 5) or ulcerative colitis in clinical remission (defined by a Mayo score \< 3 and no subscore \> 1) for at least 3 months * Social Security coverage Exclusion Criteria: * Pregnant or breastfeeding woman * Patient under legal guardianship * Cardiovascular or rheumatic conditions contraindicating participation in sports * Neurological conditions with residual deficits contraindicating participation in sports * Refusal or inability to consent to participation
Where it's running
-
Service de Gastro-Entérologie, CHU Toulouse, Hôpital Rangueil, 1 avenue Jean Poulhès
Toulouse, France Recruiting
Study contacts
- Study coordinator: Cyrielle GILLETTA, MD
- Email: gilletta.c@chu-toulouse.fr
- Phone: 05 61 31 22 31
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for inflammatory bowel disease in southeastern Korea
This study is collecting information from patients with Crohn's disease and ulcerative colitis in southeastern Korea to see how these conditions develop and change over time.
-
Switching to ustekinumab for kids with Crohn's or ulcerative colitis who developed psoriasis after anti-TNF therapy
This study tests whether switching to ustekinumab helps children with inflammatory bowel disease who developed psoriasis while on anti-TNF drugs.
-
Fecal Transplants from Dai vs Han Donors for Ulcerative Colitis
This study tests whether fecal microbiota transplantation from healthy Dai donors improves symptoms in adults with ulcerative colitis more than transplantation from healthy Han donors.
-
Longitudinal Immunophenotyping of People with Inflammatory Bowel Disease
This study will follow adults with Crohn's disease or ulcerative colitis (and some healthy relatives) over three years to see how their immune cells change over time and how genetics and diet relate to their disease.
-
Breast milk mirikizumab levels in lactating people using mirikizumab for IBS/IBD
This study tests how much mirikizumab passes into breast milk for people who are breastfeeding while on mirikizumab for an approved condition.
-
Real-world use of guselkumab in Crohn’s disease and ulcerative colitis
This study tests how long guselkumab stays in the bodies of adults with moderate-to-severe Crohn’s disease or ulcerative colitis treated in real-world clinical settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.